Efficacy and Safety of Steroids in Acute Heart Failure: A Systematic Review and Meta-analysis
Main Article Content
Keywords
Acute heart failure, Corticosteroids, Mortality.
Abstract
Background: Persistent congestion in acute heart failure (AHF) is associated with worse clinical outcomes. The use of steroids may provide therapeutic benefits by alleviating congestion, overcoming diuretic resistance, and mitigating the harmful effects of neurohormonal activation. This approach could potentially improve hemodynamic status and support better management of AHF, ultimately leading to enhanced patient recovery and reduced complications.
Objective: To evaluate the efficacy and safety of steroids in acute heart failure (AHF) as compared to the standard of care (SOC).
Search strategy: We used PubMed, Scopus, Google Scholar, and a manual search to identify Randomized controlled trials published up to October 15, 2024.The protocol was registered in PROSPERO (CRD42024601261)
Selection Criteria: All full-text randomized control trials (RCTs) that investigated steroids in heart failure were included. Results were pooled, where appropriate, using a random-effects model.
Results: Three RCTs with 563 participants [282 Steroid, 281 (SOC)] were identified. No statistically significant difference is seen in mortality as well as NT-proBNP levels between the steroid plus SOC and control group (RR=0.59, 95% CI=0.06–6.13, p=0.66, (I²=51%, p=0.15) and (MD=0.14, 95% CI=−0.62 to 0.90, p=0.71, I²=91%, p<0.0006), respectively.
Conclusion: Steroids have no significant effect on all-cause mortality or NT-proBNP levels in patients with AHF.
References
2. Kurmani S, Squire I. Acute Heart Failure: Definition, Classification and Epidemiology. Curr Heart Fail Rep. 2017 ;14(5):385-392.
3. Mozaffarian D, Benjamin EJ, Go AS, et al. : Heart disease and stroke statistics--2015 update: A report from the American Heart Association. Circulation. 2015; 131(4): e29–322.
4. Tung YC, Chou SH, Liu KL, et al.: Worse Prognosis in Heart Failure Patients with 30-Day Readmission. Acta Cardiol Sin. 2016; 32(6): 698–707.
5. Heidenreich PA, Trogdon JG, Khavjou OA, et al.: Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation. 2011; 123(8): 933–44.
6. Dec GW. Management of acute decompensated heart failure. Curr Probl Cardiol. 2007;32:321–366.
7. Liu C, Liu K, Cope-Adhf Study Group. Cardiac outcome prevention effectiveness of glucocorticoids in acute decompensated heart failure: COPE-ADHF study. Journal of Cardiovascular Pharmacology. 2014 Apr 1;63(4):333-8.
8. Kamran H, Tang WW. Medical management of acute heart failure. Faculty Reviews. 2021;10.
9. Elster SK, Braunwald E, Wood HF. A study of C-reactive protein in the serum of patients with congestive heart failure. American heart journal. 1956 Apr 1;51(4):533-41.
10. Cotter G, Davison BA, Freund Y, Voors AA, Edwards C, Novosadova M, Takagi K, Hayrapetyan H, Mshetsyan A, Mayranush D, Cohen‐Solal A. Burst steroid therapy for acute heart failure: The CORTAHF randomized, open‐label, pilot trial. European Journal of Heart Failure. 2024 Oct.
11. PRISMA 2020 Checklist. Accessed 18/11/2024, https://www.prisma-statement.org/prisma-2020-checklist
12. Sterne JA, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR. RoB 2: a revised tool for assessing risk of bias in randomised trials. bmj. 2019 Aug 28;366.
13. Higgins JPT, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions. 2nd. Chichester, England: John Wiley & Sons; 2019. http://www.training. cochrane.org/handbook.
14. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of internal medicine. 2001 Dec 4;135(11):982-9.
15. Schünemann H. Bro ek J, Guyatt G, Oxman A, editors. GWG. GRADE handbook for grading quality of evidence and strength of recommendations [Internet]. 2013
16. McMaster University (developed by Evidence Prime, Inc.). GRADEpro GDT: GRADEpro guideline development tool.University, 2015
17. Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, Mann DL, Margulies KB, McNulty SE, Mentz RJ, Redfield MM. Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial. JAMA cardiology. 2017 Sep 1;2(9):950-8.
18. Milo O, Cotter G, Kaluski E, Brill A, Blatt A, Krakover R, Vered Z, Hershkoviz R. Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. American Journal of Cardiology. 2003 Jul 15;92(2):222-6.
19. Garofalo M, Corso R, Tomasoni D, Adamo M, Lombardi CM, Inciardi RM, Gussago C, Di Mario C, Metra M, Pagnesi M. Inflammation in acute heart failure. Frontiers in Cardiovascular Medicine. 2023 Nov 17;10:1235178.
20. Anderton JL, Kincaid’Smith P. Diuretics I: Physiological and pharmacological considerations. Drugs. 1971 Jan;1:54-81.
21. Newman DA. Reversal of intractable cardiac edema with prednisone (meticorten). The Journal of the Florida Medical Association. Florida Medical Association. 1959 Jan;45(7):778-82.
22. Mickerson JN, Swale J. Diuretic effect of steroid therapy in obstinate heart failure. British Medical Journal. 1959 Apr 4;1(5126):876.
23. Michael Felker G. Diuretic management in heart failure. Congestive Heart Failure. 2010 Jul;16:S68-72.
24. Testani JM, Cappola TP, Brensinger CM, Shannon RP, Kimmel SE. Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. Journal of the American College of Cardiology. 2011 Jul 19;58(4):375-82.
25. De Vecchis R, Ciccarelli A, Pucciarelli A. Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?. Journal of Cardiovascular Medicine. 2010 Aug 1;11(8):571-4.
26. Tian Y, Chen Y, Deng B, Liu G, Ji ZG, Zhao QZ, Zhen YZ, Gao YQ, Tian L, Wang L, Ji LS. Serum uric acid as an index of impaired renal function in congestive heart failure. Journal of geriatric cardiology: JGC. 2012 Jun;9(2):137.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.